The Benefit of Healthy Lifestyle in the Era of New Medications to Treat Obesity

被引:4
|
作者
Grave, Riccardo Dalle [1 ,2 ]
机构
[1] Villa Garda Hosp, Dept Eating & Weight Disorders, Garda, VR, Italy
[2] Via Monte Baldo 89, I-37016 Garda, VR, Italy
关键词
obesity; treatment; semaglutide; terzipatide; GLP-1; agonists; physical activity; exercise; Mediterranean diet; weight loss; lifestyle modification; WEIGHT-LOSS;
D O I
10.2147/DMSO.S447582
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Incretin-based medications for treating obesity produce substantial short- and long-term weight loss and improve obesityrelated comorbidities. However, associating lifestyle modification with new medications to treat obesity is generally advisable for several reasons. Firstly, healthy eating patterns and physical activity may offer important additional benefits, enhancing the patient's health and well-being. In addition, regular specialist counselling in lifestyle modification can help patients maintain their motivation levels and develop specific skills for addressing obstacles during the lengthy process of weight loss and maintenance, potentially improving outcomes in the long term. Given the high efficacy of the new weight-loss drugs, it would be timely to streamline and simplify the current gold standard of obesity management based on lifestyle modification. For example, it now seems redundant to prescribe strict diets or meal replacements to reduce calorie intake, or to recommend patients practice 200 to 300 minutes of moderateto-vigorous-intensity exercise for enhanced weight loss. Moderate calorie restriction and, at least 150 minutes of moderate-intensity aerobic exercise and two sessions of muscle-strengthening activities per week may be more achievable and appropriate goals for sustainable weight loss in most patients on pharmaceutical obesity treatment. As regards lifestyle modification counselling, future studies should assess its optimal intensity and duration in the "new medications for obesity era".
引用
收藏
页码:227 / 230
页数:4
相关论文
共 50 条
  • [1] Twitter and Communicating Stigma about Medications to Treat Obesity
    Haggerty, Treah
    Sedney, Cara L.
    Cowher, Abigail
    Holland, Dylan
    Davisson, Laura
    Dekeseredy, Patricia
    HEALTH COMMUNICATION, 2023, 38 (14) : 3238 - 3242
  • [2] Increasing Motivation for Lifestyle Change Is Not Enough to Treat Obesity
    Wittleder, Sandra
    Jay, Melanie
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (06) : 901 - 902
  • [3] Access to new medications to treat schizophrenia
    Tami L. Mark
    Riad Dirani
    Eric Slade
    Patricia A. Russo
    The Journal of Behavioral Health Services & Research, 2002, 29 : 15 - 29
  • [4] Access to new medications to treat schizophrenia
    Mark, TL
    Dirani, R
    Slade, E
    Russo, PA
    JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH, 2002, 29 (01): : 15 - 29
  • [5] Game changers: do new medications make lifestyle-based treatment of obesity obsolete?
    Lewis, Kristina H.
    Moore, Justin B.
    Ard, Jamy D.
    OBESITY, 2024, 32 (02) : 237 - 239
  • [6] Healthy lifestyle interventions in general practice: Part 14: Lifestyle and obesity
    Derman, E. W.
    Whitesman, S.
    Dreyer, M.
    Patel, D. N.
    Nossel, C. J.
    Lambert, E., V
    Shwellnus, M. P.
    SOUTH AFRICAN FAMILY PRACTICE, 2011, 53 (02) : 105 - 118
  • [7] Medications to Treat Obesity Lack Patient-Oriented Evidence
    Bich-May Nguyen
    AMERICAN FAMILY PHYSICIAN, 2018, 97 (01) : 8 - 8
  • [8] Treatment of Hepatitis C in the Pre-DAA's Era: Treat Now or Wait for New Medications?
    Herrera, Jorge L.
    PRACTICAL GASTROENTEROLOGY, 2010, 34 (06) : 13 - 19
  • [9] Economic evaluation of lifestyle interventions to treat overweight or obesity in children
    Hollingworth, W.
    Hawkins, J.
    Lawlor, D. A.
    Brown, M.
    Marsh, T.
    Kipping, R. R.
    INTERNATIONAL JOURNAL OF OBESITY, 2012, 36 (04) : 559 - 566
  • [10] Economic evaluation of lifestyle interventions to treat overweight or obesity in children
    W Hollingworth
    J Hawkins
    D A Lawlor
    M Brown
    T Marsh
    R R Kipping
    International Journal of Obesity, 2012, 36 : 559 - 566